Toxicokinetics of CBX129801, a Bio active C peptide for Potential Replacement Therapy in Type 1 Diabetic PeripheralNeuropathy, Following Subcutaneous Injection of CBX129801 in Rats in a 6-Month Study with a 7-Week Recovery Period


To assess the toxicokinetics (TK) of CBX129801 in Sprague Dawley Rats following once weekly subcutaneous injection for 26 doses.